SIPC Statistics

Total Valuation

Sabaa International Company for Pharmaceutical and Chemical Industry has a market cap or net worth of EGP 332.50 million. The enterprise value is 363.54 million.

Market Cap	332.50M
Enterprise Value	363.54M

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Sabaa International Company for Pharmaceutical and Chemical Industry has 250.00 million shares outstanding. The number of shares has increased by 7.36% in one year.

Shares Outstanding	250.00M
Shares Change (YoY)	+7.36%
Shares Change (QoQ)	-79.97%
Owned by Insiders (%)	79.23%
Owned by Institutions (%)	n/a
Float	51.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.94
PB Ratio	3.10
P/FCF Ratio	43.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 95.33, with an EV/FCF ratio of 47.41.

EV / Earnings	-55.14
EV / Sales	28.43
EV / EBITDA	95.33
EV / EBIT	290.88
EV / FCF	47.41

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.29.

Current Ratio	1.58
Quick Ratio	0.23
Debt / Equity	0.29
Debt / EBITDA	8.26
Debt / FCF	4.11
Interest Coverage	0.94

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	77,492
Profits Per Employee	-39,959
Employee Count	165
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +86.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+86.42%
50-Day Moving Average	0.91
200-Day Moving Average	0.78
Relative Strength Index (RSI)	63.67
Average Volume (20 Days)	4,530,939

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sabaa International Company for Pharmaceutical and Chemical Industry had revenue of EGP 12.79 million and -6.59 million in losses. Loss per share was -0.03.

Revenue	12.79M
Gross Profit	7.67M
Operating Income	1.25M
Pretax Income	-5.79M
Net Income	-6.59M
EBITDA	3.79M
EBIT	1.25M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 456,493 in cash and 31.49 million in debt, giving a net cash position of -31.04 million or -0.12 per share.

Cash & Cash Equivalents	456,493
Total Debt	31.49M
Net Cash	-31.04M
Net Cash Per Share	-0.12
Equity (Book Value)	107.42M
Book Value Per Share	0.43
Working Capital	24.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.86 million and capital expenditures -1.19 million, giving a free cash flow of 7.67 million.

Operating Cash Flow	8.86M
Capital Expenditures	-1.19M
Free Cash Flow	7.67M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 60.00%, with operating and profit margins of 9.77% and -51.36%.

Gross Margin	60.00%
Operating Margin	9.77%
Pretax Margin	-45.29%
Profit Margin	-51.36%
EBITDA Margin	29.65%
EBIT Margin	9.77%
FCF Margin	59.97%

Dividends & Yields

Sabaa International Company for Pharmaceutical and Chemical Industry does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.36%
Shareholder Yield	-7.36%
Earnings Yield	-1.91%
FCF Yield	2.31%

Stock Splits

The last stock split was on November 8, 2022. It was a forward split with a ratio of 5.

Last Split Date	Nov 8, 2022
Split Type	Forward
Split Ratio	5

Scores

Sabaa International Company for Pharmaceutical and Chemical Industry has an Altman Z-Score of 2.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	n/a